DRKS - German Clinical Trials Register

Here you will find an up-to-date overview of all studies that have been registered to date on the subject of COVID-19 in the German Clinical Trials Register (DRKS).

Search DRKS for COVID-19 Trials

The DRKS is an open access online register for clinical trials conducted in Germany, which allows all users to search, register and share information on clinical trials.

The DRKS now contains over 14.000 studies. Currently, around 2.000 studies are added annually.

You will find basic information like the title, short descriptions, inclusion and exclusion criteria, status and outcomes on every trial.

In order to search for clinical trials you can either enter a search term into the search box or you can use the extended search to refine your results. This allows for example to search specifically for trials currently recruiting patients.

The DRKS is a non- profit organization and is located at the Federal Institute for Drugs and Medical Devices (BfArM). BfArM is a governmental institution within the scope of the Federal Ministry of Health (BMG).

The DRKS is an approved Primary Register in the WHO network since October 2008 and thus meets the requirements of the ICMJE.

Research-based physicians are obliged by their professional code of conduct to observe the Declaration of Helsinki. In the currently valid version of 2013, §35 states: "Every research study involving human subjects must be registered in a publicly accessible database before recruitment of the first subject.” Therefore, please check (if necessary together with the responsible ethics committee) whether you need to register your study in a publicly accessible study register (such as DRKS).

For DRKS, trials must meet the following requirements:

For further details, see our FAQ "Which trials can/should be registered with DRKS?” Independent of this and of the requirements of medical journals, please also observe any national regulations.

Last Modified: 08-18-2022